Virology Journal

Papers
(The H4-Index of Virology Journal is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
DF-1-Derived exosomes mediate transmission of reticuloendotheliosis virus and resist REV-specific antibodies464
The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays147
PPP2R5D promotes hepatitis C virus infection by binding to viral NS5B and enhancing viral RNA replication93
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak91
Flavivirus replication kinetics in early-term placental cell lines with different differentiation pathways90
The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers65
Molecular detection and genomic characterization of Samak Micromys paramyxovirus-1 and -2 in Micromys minutus, Republic of Korea60
Phylogenetic analysis and transmission networks highlight the role of older adults in the transmission of HIV-1 in northern Zhejiang, China58
The value of promoter methylation of fibroblast factor 21 (FGF21) in predicting the course of chronic hepatitis B and the occurrence of oxidative stress58
Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation57
Targeting the conserved coronavirus octamer motif GGAAGAGC is a strategy for the development of coronavirus vaccine52
Molecular characterization of a reptarenavirus detected in a Colombian Red-Tailed Boa (Boa constrictor imperator)51
Human Immunodeficiency Virus (HIV) viral load suppression status and associated factors among pregnant women receiving Highly Active Antiretroviral Therapy (HAART) in Ethiopia50
The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice49
Antiviral screening of natural, anti-inflammatory compound library against African swine fever virus47
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein42
Interaction of HnRNP F with the guanine-rich segments in viral antigenomic RNA enhances porcine reproductive and respiratory syndrome virus-2 replication42
Central nervous system infection with Seoul Orthohantavirus in a child after hematopoietic stem cell transplantation: a case report42
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine41
First identification and isolation of equine herpesvirus type 1 in aborted fetal lung tissues of donkeys40
HIV-1 molecular transmission network and drug resistance in Chongqing, China, among men who have sex with men (2018–2021)39
Reactivation of occult hepatitis B virus infection in a renal transplant recipient39
Identification and characterization of novel CRESS-DNA viruses in the human respiratory tract37
Activating transcription factor 3 induces oxidative stress and genotoxicity, transcriptionally modulating metastasis-related gene expression in human papillomavirus-infected cervical cancer37
Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 202336
Clinical features and risk factors for Epstein-Barr virus-associated encephalitis: a retrospective cohort study36
Detection of human adenoviruses in influenza-negative patients with respiratory tract infections in Nanning, China33
Virome and nrEVEome diversity of Aedes albopictus mosquitoes from La Reunion Island and China33
Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action33
SARS-CoV2 RT-PCR assays: In vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence32
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza31
PREB inhibits the replication of prototype foamy virus by affecting its transcription31
0.10833597183228